Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20971391

Export

Selection :

Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

Author
SCHULTHEIS, Anne M1 ; LURJE, Georg1 ; HIRTE, Hal4 ; FLEMING, Gini5 ; ROMAN, Lynda1 ; LENZ, Heinz-Josef1 ; RHODES, Katrin E1 ; WU ZHANG1 ; DONGYUN YANG1 ; GARCIA, Agustin A1 ; MORGAN, Robert2 ; GANDARA, David3 ; SCUDDER, Sidney3 ; OZA, Amit4
[1] University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, United States
[2] City of Hope National Medical Center, Duarte, California, United States
[3] University of California, Davis Cancer Center, Sacramento, California, United States
[4] Princess Margaret Hospital, Toronto, Ontario, Canada
[5] University of Chicago, Chicago, Illinois, United States
Source

Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7554-7563, 10 p ; ref : 41 ref

CODEN
CCREF4
ISSN
1078-0432
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
American Association for Cancer Research, Philadelphia, PA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Antiangiogénique Anticancéreux Bévacizumab Cancer de l'ovaire Cyclophosphamide Facteur croissance endothélium vasculaire Génotype Polymorphisme Pronostic Récidive Traitement Variabilité génétique Anti-VEGF Agent alkylant Anticorps monoclonal Cancer Dérivé de l'oxazaphosphinane Moutarde à l'azote Pathologie de l'appareil génital femelle Pathologie des ovaires Tumeur maligne
Keyword (en)
Antiangiogenic agent Antineoplastic agent Bevacizumab Ovary cancer Cyclophosphamide Vascular endothelium growth factor Genotype Polymorphism Prognosis Relapse Treatment Genetic variability Alkylating agent Monoclonal antibody Cancer Oxazaphosphinane derivatives Nitrogen mustard Female genital diseases Ovarian diseases Malignant tumor
Keyword (es)
Antiangiogenico Anticanceroso Bevacizumab Cáncer del ovario Ciclofosfamida Factor crecimiento endotelio vascular Genotipo Polimorfismo Pronóstico Recaida Tratamiento Variabilidad genética Agente alquilante Anticuerpo monoclonal Cáncer Oxazafosfinano derivado Mostaza al nitrógeno Aparato genital hembra patología Ovario patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors

Discipline
Gynecology. Andrology. Obstetrics Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20971391

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web